acsl4: biomarker, mediator and target in quadruple negative breast cancer | oncotarget
Published 1 year ago • 59 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
0:46
oncotarget: sacituzumab govitecan in triple-negative breast cancer
-
1:13
crosstalk between triple negative breast cancer and microenvironment | oncotarget
-
9:23
inhibition of resistant triple-negative breast cancer cells | oncotarget
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
1:00
oncotarget | notch1 variants in triple-negative breast cancer
-
1:00
immune biomarkers in triple-negative breast cancer: improving the predictivity of cur... | rtcl.tv
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
1:02:45
biomarkers in breast cancer: current practice, opportunities and unmet needs
-
0:41
the importance of brca-1 testing in triple negative breast cancer
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology
-
0:15
3 year cancer survivor - stage 4 breast cancer at 22 #shorts
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
1:26
the search for biomarkers in metastatic breast cancer
-
16:02
triple negative breast cancer: immunotherapies and biomarkers
-
2:39
the role of biomarkers in guiding treatment for early-stage breast cancer
-
2:42
biomarker-driven therapies for triple-negative breast cancer
-
16:58
assessing immune biomarkers of response to anthracyclines in breast cancer
-
1:17
neoadjuvant immunotherapy in tnbc and targeted lnd in breast cancer: 2023 best of breast conference
-
55:01
advances in treatment of triple-negative breast cancer: a success story